This educational meeting will discuss the latest clinical and scientific advances in the field of colorectal cancer (CRC) and put into context the most significant treatment advances; with a focus on immunotherapy and neoadjuvant treatments. The faculty will then delve into real-world patient case studies; discussing how the latest data presented may impact clinical practice and could improve patient care. There will be opportunities for delegates to ask questions and discuss these topics with the faculty throughout the meeting.
Merck is a global science and technology company with a passion for forward-thinking discoveries. We want to develop products and solutions for a better life. That's why we take a closer look at things, ask questions and think ahead.
More than 52,000 employees in 66 countries work together with us on innovative solutions and the newest technologies in healthcare, life science and performance materials. From improving electronic devices with smarter materials to generating ultra pure water, testing the quality of food and drugs, and treating cancer, Merck always promotes opportunities to break new ground.
